NORCROSS, GA--(Marketwired - Apr 28, 2014) - RayBiotech, Inc. ("RBI") announced today that it has partnered with XCellCure, LLC ("XCellCure") to develop a proprietary cardiovascular disease diagnostic ...
Norcross, GA – July 1, 2013 - (eTeligis via ACCESSWIRE) -- RayBiotech, Inc. announced today their sponsorship of a new funding opportunity for biomedical science researchers, a program called the ...
NORCROSS, Ga., Nov. 1, 2012 /PRNewswire/ -- RayBiotech, Inc. and Abeome Corporation today announced that the companies have entered into a collaboration whereby Abeome will provide over 300 novel ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today ...
Sengenics and Raybiotech have announced that they have entered into a commercial partnership to co-brand Sengenics’ flagship protein array platform, Immunome. Sengenics Commercial Director, Matthew ...
Partnership Leverages Host Response Analysis to Predict Response to Cancer Therapy and Aid in Discovery of New Drug Combination Strategies The grant will support OncoHost and RayBiotech's combined ...
The development of oncoprotein-targeted anticancer drugs is an invaluable weapon in the war against cancer. However, cancers do not give up without a fight. They may develop multiple mechanisms of ...
Often described as synthetic antibodies, aptamers are single-stranded DNA or RNA molecules that fold into secondary structures which can bind to target molecules with high affinity and specificity. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results